SOPH · SOPHiA GENETICS SA
$7.50
-0.12 (-1.57%)
At close · Aug 14
Market Cap
$638.46M
Shares
85.13M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$7.50
Open$7.70
Day$7.40–7.70
52W close$3.12–7.71
Avg vol 30d389K
Short int768K · 0.9% float · 2.7d
Short vol29%
Last earningsAug 4, 2026
DataJul 2021–Aug 2026
Up next
Next earnings call
Nov 3, 2026
Est · unconfirmed
· in 11 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Strong Buy
Momentum
Very Strong
Sentiment
Bullish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+47%
above
Price vs 50-day avg
+28%
above
RSI (14)
67
neutral
MACD trend
Positive
52-week position
95%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+28%
trailing
6-month return
+63%
trailing
YTD return
+61%
this year
Relative strength
+49%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $6 › 200d $5 — 50d above 200d
Institutional flow
Accumulating
+44% holders QoQ · +26 funds added
Insider flow
Accumulating
Net +$97.8K over 90 days · 50% sells
Short interest
Rising
0.90% of float · ▲ +16.2% MoM · 2.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
72 holders — near 3-yr high, broad support
Squeeze score
62
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
70%
annualized · 1-yr
Max drawdown
−26%
past year
ATR
6.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Prior guidance
period ended
· from the Earnings Call filed Sep 30, 2025
Revenue
· 2025
$75M – $77M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+47%
Bullish
Price vs 50-day avg
+28%
Bullish
RSI (14)
67
Neutral
MACD trend
Positive
Bullish
52-week position
95%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $6 › 200d $5 — 50d above 200d
Institutional flow
Accumulating
+44% holders QoQ · +26 funds added
Insider flow
Accumulating
Net +$97.8K over 90 days · 50% sells
Short interest
Rising
0.90% of float · ▲ +16.2% MoM · 2.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
72 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $3
Now $8 · 95%
Range high $8
vs 200-day avg +47%
vs 50-day avg +28%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Health Information Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SOPH
this stock
SOPHiA GENETICS SA
|
$638.46M | +60.6% | — | — | 0.9% |
|
VEEV
Veeva Systems Inc
|
$39.60B | +9.2% | +28.1% | 43.2 | 4.5% |
|
PMDIY
Pro Medicus Ltd./ADR
|
$14.08B | -18.8% | — | — | 0.0% |
|
BTSG
BrightSpring Health Services, Inc.
|
$12.21B | +64.8% | +28.2% | 37.4 | 4.2% |
|
TEM
Tempus AI, Inc.
|
$9.40B | -11.8% | +83.4% | — | 18.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SOPH | -2.7% | +27.8% | +63.0% | +32.3% | +60.6% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | -3.1% | +23.3% | +49.3% | +28.4% | +46.8% |
Key facts
CIK
1840706
CUSIP
H82027105
13F (30d)
69 filings
69 filers
Visit website
Investor relations